Basel, Switzerland

Frank Otto Gombert

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 6 CIPO patents and 8 EPO patents, primarily in Peptidomimetics Research. Top assignees: Polyphor Ag, Unversität Zürich. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Otto Gombert. Retrieved from https://idiyas.com/inventor/frank-otto-gombert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 66.7


 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Beta-Hairpin
Peptidomimetics
Elastase Inhibitors
CXCR4 Antagonists
Template-Fixed
CXC4 Antagonists
CCR10 Antagonistic
Biomolecular Design
12 patents (USPTO):Explore Patents

Title: The Innovative Mind of Frank Otto Gombert

Introduction

Frank Otto Gombert, based in Basel, Switzerland, is a prolific inventor with a remarkable collection of 12 patents. His work primarily revolves around the development of peptidomimetics, showcasing his innovative contributions to medical science, particularly in addressing elastase-related diseases and HIV infections.

Latest Patents

One of Frank Otto Gombert's latest patents, titled "Beta-hairpin peptidomimetics as selective elastase inhibitors," focuses on compounds designed to inhibit elastase activity, specifically targeting human neutrophil elastase. These compounds hold potential for preventing infections and diseases associated with elastase activity. Furthermore, Gombert's research extends to peptidomimetics formulated to treat or slow down diseases like cancer and various immunological and pulmonary disorders.

Another significant patent showcases beta-hairpin peptidomimetics that can prevent HIV infections and address conditions influenced by CXCR4 receptor activity. The pharmacological properties of these compounds could aid patients with immunosuppression during apheresis procedures, emphasizing their versatility and clinical importance.

Career Highlights

Frank Otto Gombert's professional journey includes impactful roles at notable institutions such as Polyphor AG and the University of Zurich. His expertise in the field has led to groundbreaking research and advancements in the synthesis of therapeutic agents, especially through innovative mixed solid- and solution phase synthetic strategies.

Collaborations

Throughout his career, Gombert has collaborated with esteemed colleagues, including Daniel Obrecht and Alexander Lederer. These partnerships have fostered a collaborative environment in which innovative ideas flourish, leading to significant advancements in their respective fields.

Conclusion

Frank Otto Gombert embodies the spirit of innovation, with a focus on creating solutions that address critical health issues. His contributions through various patents reflect a commitment to enhancing medical therapies and improving patient outcomes. As he continues his work, the potential impact of his inventions promises to be far-reaching and transformative in the realms of medicine and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…